European Healthcare20 March 2008

M&A activity in the healthcare sector is showing no sign of dwindling. Indeed, in the past three years the sector, which comprises medical technology and devices, pharmaceuticals, hospitals and other services, and biotechnology, has remained a focus for M&A activity, with some 2,569 M&A transactions globally worth €477bn, according to mergermarket. Furthermore, around a third of these deals in both value and volume terms have involved target companies in Europe.

Table of Contents

1. Foreword

2. European Healthcare

3. The future for medical technology and devices

4. Case Study: Nucletron

5. Forces for change in the pharmaceutical sector

6. Healthcare services going private

7. Case Study: Gambro

8. An uneven battle in European biotech?

9. Case Study: Arrow Therapeutics

10. European Healthcare M&A Historical Data

11. Contacts

We hope you find this report useful and we would particularly welcome any feedback or questions you might have.

Download PDF (859 kb)

Back to Remark